1 day ago · Analysts have recently evaluated Illumina and provided 12-month price targets. The average target is $153.86, accompanied by a high estimate of $247.00 and a low estimate of $100.00.

5 days ago · Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling subdued demand for its genetic tests and diagnostic tools, sending shares ...

2 days ago · ILMN's current price target is $160.15. Learn why top analysts are making this stock forecast for Illumina at MarketBeat.

4 days ago · The 18 analysts with 12-month price forecasts for Illumina stock have an average target of 160.28, with a low estimate of 115 and a high estimate of 247. The average target predicts an increase of 44.32% from the current stock price of 111.06.

Feb 3, 2025 · The average prediction of analysts places 'Revenue- Service and other revenue' at $173.11 million. ... Shares of Illumina have experienced a change of -2.4% in the past month compared to the +2.7% ...

Jan 30, 2025 · For Illumina, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This...

Jan 17, 2025 · Firstly, Illumina’s preliminary fourth-quarter revenue exceeded expectations, signaling the first instance of growth for the company in 2024, which is a positive indicator of its recovery...

Discover Illumina's earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers.

May 24, 2024 · American biotechnology company Illumina (NASDAQ:ILMN) could offer a 44.4% upside potential in the next twelve months, as per Wall Street’s average price target. Analysts are cautiously optimistic...

Jan 13, 2025 · To optimize analysis of the vast amounts of data involved in multiomic research, Illumina and NVIDIA will combine advancements in AI with multiomic data at scale.